Louisa Stone
Manager of Investor Relations
Replay available
Viridian Therapeutics, Inc. (VRDN) Q4 2022 Earnings Call
Viridian Therapeutics, Inc. (NASDAQ: VRDN) Q4 2022 earnings conference call, held 2023-03-08. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Scott Myers
President and Chief Executive Officer
Christian Humer
Chief Financial and Business Officer
Gavin Clark-Gentner
Analyst, Evercore ISI
Thomas Smith
Analyst, SVP Securities
Kambiz Yazdi
Analyst, Jefferies
Laura Chico
Analyst, Wedbush Securities
Jason Butler
Analyst, JMP Securities
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Viridian Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:04.591 Welcome to the Viridian Therapeutics fourth quarter and full year 2022 00:00:04.591 -- 00:00:08.953 conference call. At this time, all participants are on a listen-only mode. 00:00:08.953 -- 00:00:12.574 Later, we will conduct a question and answer session and instructions will be given at 00:00:12.574 -- 00:00:15.955 that time. As a reminder, this conference is being recorded. 00:00:15.955 -- 00:00:18.976 I would now like to hand the floor over to Ms. 00:00:18.976 -- 00:00:22.158 Louisa Stone, Manager of Investor Relations at Viridian. 00:00:22.158 -- 00:00:24.558 Please go ahead. 00:00:24.568 -- 00:00:29.591 Thank you and welcome everyone to our fourth quarter and full year 2022 00:00:29.591 -- 00:00:34.734 conference call. The press release reporting our financial results is available 00:00:34.734 -- 00:00:40.097 on the investors page of our corporate website at www.viridiantherapeutics.com. 00:00:42.539 -- 00:00:47.583 Joining me on the call this morning are Scott Myers, our President and Chief 00:00:47.583 -- 00:00:53.570 Executive Officer, Christian Humer, our Chief Financial and Business Officer, 00:00:53.570 -- 00:00:58.632 Dr. Deepa Rajagopalan, our Chief Product and Strategy Officer, 00:00:58.632 -- 00:01:04.555 and Todd James, Senior Vice President, Corporate Affairs and Investor Relations. 00:01:04.555 -- 00:01:10.038 Before we begin, I would like to remind everyone that this conference call and webcast 00:01:10.038 -- 00:01:15.240 will contain forward-looking statements regarding our financial outlook in addition 00:01:15.240 -- 00:01:20.563 to regulatory, product development, and commercialization plans and research 00:01:20.563 -- 00:01:22.128 activities. 00:01:22.128 -- 00:01:27.372 These statements are subject to r...